Albree Tower‐Rader

Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

Martin S. Maron, Ahmad Masri, Lubna Choudhury et al. · Journal of the American College of Cardiology · 2023 · 178 citations · Full text

Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction

Milind Y. Desai, Anjali Owens, Kathy Wolski et al. · JAMA Cardiology · 2023 · 133 citations · Full text

Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality

Brett W. Sperry, Michael N. Vranian, Albree Tower‐Rader et al. · JACC. Cardiovascular imaging · 2017 · 101 citations

Regional Variation, Biochemistry, Physiology +3

Incremental Prognostic Utility of Left Ventricular Global Longitudinal Strain in Hypertrophic Obstructive Cardiomyopathy Patients and Preserved Left Ventricular Ejection Fraction

Albree Tower‐Rader, Jorge J. Betancor, Zoran Popović et al. · Journal of the American Heart Association · 2017 · 46 citations · Full text

Multimodality Imaging in Hypertrophic Cardiomyopathy for Risk Stratification

Albree Tower‐Rader, Christopher M. Kramer, Stefan Neubauer et al. · Circulation Cardiovascular Imaging · 2020 · 46 citations · Full text

Cardiomyopathy, Heart Failure, Cardiogenic Shock +14